Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
06/2012
06/28/2012US20120165329 Compounds and methods for kinase modulation, and indications therefor
06/28/2012US20120165327 Spiropiperidines for use as tryptase inhibitors
06/28/2012US20120165322 Rho kinase inhibitors
06/28/2012US20120165299 Combination medicament
06/28/2012US20120165295 Compounds, Compositions and Methods for Treating Ocular Conditions
06/28/2012US20120165293 Synthesis of prostanoids
06/28/2012US20120165292 METHODS FOR TREATMENT OF MULTIPLE MYELOMA USING CYCLOPROPANE CARBOXYLIC ACID {2-(Is)-(3-eTHOXY-4METHOXY-PHENYL)-2-METHANESULFONYL-ETHYL}-3-OXO-2.3-DIHYDRO-1H-ISOINDOL-4-YL}-AMIDE
06/28/2012US20120165273 Eye drops
06/28/2012US20120165272 Tear Substitutes
06/28/2012US20120165271 Methods of treating retinitis pigmentosa
06/28/2012US20120165251 Diabetes therapy
06/28/2012US20120164213 Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and application
06/28/2012US20120164161 Antibodies and Uses Thereof
06/28/2012US20120164159 Humanised Antibodies to Toll-Like Receptor 2 and Uses Thereof
06/28/2012US20120164106 Adeno-associated virus virions with variant capsid and methods of use thereof
06/28/2012US20120164087 Human Serum Albumin-Based Topical Ointment for Treatment of Acne, Psoriasis, Egfr-Induced Toxicity, Premature Skin Aging and Other Skin Conditions
06/28/2012US20120164067 Methods of preventing or treating pain using anti-ngf antibodies that selectively inhibit the association of ngf with trka, without affecting the association of ngf with p75
06/28/2012CA2822787A1 Novel substituted isoquinoline derivative
06/28/2012CA2821969A1 Tear substitutes
06/28/2012CA2817688A1 Diphenyl sulfide derivative and pharmaceutical product which contains same as active ingredient
06/27/2012EP2468772A2 Antibodies to EGFL7 and methods for their use
06/27/2012EP2468729A1 Novel indazole derivative
06/27/2012EP2468292A1 Antisecretory factors for treating intraocular hypertension
06/27/2012EP2468111A1 Compositions and applications of carotenoids of improved absorption and bioavailability
06/27/2012EP2467385A1 Renin inhibitors
06/27/2012EP2467376A1 Bicyclic heteroaryl inhibitors of pde4
06/27/2012EP2467135A2 Desferrioxamine-metal complexes for the treatment of immune-related disorders
06/27/2012EP1562909B1 Ophthalmic compositions for treating ocular hypertension
06/27/2012CN102516383A Novel mite allergen
06/27/2012CN102516263A Spirotricyclic compound, its preparation method, and pharmaceutical composition containing it as well as application thereof
06/27/2012CN102516101A Treatment of faecal incontinence and other conditions with 1R, 2S-methoxamine
06/27/2012CN102512682A Medicinal composition for treating noise-induced hearing impairment and application of medicinal composition
06/27/2012CN102512677A Application of guanylate cyclase inhibitor to preparation of medicament for inhibiting myopia
06/27/2012CN102512603A Traditional Chinese medicinal composition for treating acute infectious conjunctivitis
06/27/2012CN102512589A Medicine for treating early sudden deafness
06/27/2012CN102512524A Medicine for treating secretory otitis media and acute suppurative otitis media
06/27/2012CN102512467A Ophthalmic preparation of panax notoginseng saponins and preparation method thereof
06/27/2012CN102512433A Application of digitoflavone-7-O-beta-D-glucuronide in fundus disease treatment
06/27/2012CN102512428A Applications of zinc gluconate tablets and six vitamins pills in treatment of ametropia
06/27/2012CN102512420A Officinal composite using Rebamipide officinal salt as active ingredient
06/27/2012CN102512407A Application of utilizing beta-phenylalanine compounds as aldose reductase inhibitors
06/27/2012CN102512396A Novel atenolol tablets and preparation method thereof
06/27/2012CN102512362A Formula and preparation method of compound ciprofloxacin eye drops
06/27/2012CN102512357A Nerve growth factor ophthalmic gel and preparation method thereof
06/27/2012CN102512356A Intraocular drug delivery systems
06/27/2012CN102018949B Traditional Chinese medicine composition for treating vertigo
06/27/2012CN102000194B Traditional Chinese medicine composition for treating tympanitis and preparation method thereof
06/27/2012CN101744938B Pharmaceutical composition and preparation method thereof
06/27/2012CN101732577B Medicament for treating Meniere's disease
06/27/2012CN101613679B Rhabdovirus with recombination superoxide dismutase gene and preparation and application thereof
06/27/2012CN101607005B Application of Chinese medicinal composition in preparing medicament for treating conjunctivitis
06/27/2012CN101595096B Substituted carbinol compound
06/26/2012USRE43497 Anti-MIF antibodies
06/26/2012US8207215 Ketorolac tromethamine compositions for treating or preventing ocular pain
06/26/2012US8207194 Compounds having a 4-pyridylalkylthio group as a substituent
06/26/2012US8207182 Substituted cyclic urea derivatives and the use thereof as vanilloid receptor 1 modulators
06/26/2012US8207137 administering a therapeutically effective amount of an active agent selected from the group consisting of a protein substance including all or part of a disintegrin domain of an adamalysin or a derivative thereof
06/26/2012US8207119 Ophthalmological composition
06/26/2012US8206723 having structurally modified terminal ends which confers enhanced half-life and biological activity for use in prevention and treatment of neuromuscular and pain disorders; cosmetics
06/26/2012US8206719 KDR peptides and vaccines comprising the same
06/26/2012US8206714 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFa
06/26/2012US8206708 Vascular endothelial growth factor 2
06/26/2012CA2691914C Pharmaceutical compositions and methods of treating dry eye disorders
06/26/2012CA2661607C Compositions and methods for treating or preventing glaucoma or progression thereof
06/26/2012CA2536185C Drug delivery system by administrating fine particles to sub-tenon
06/26/2012CA2458126C Composition for stabilizing hyaluronic acid
06/21/2012WO2012083195A2 Magnetic control of eyelid position
06/21/2012WO2012082003A1 Product of natural origin for ophthalmic treatment and obtaining procedure
06/21/2012WO2012080497A2 Methods of treatment and prevention of eye diseases
06/21/2012WO2012079497A1 Bromfenac organic salts and preparation method, composition and use thereof
06/21/2012WO2012079419A1 Pharmaceutical composition for treating macular degeneration
06/21/2012WO2012079203A1 Puerarin hydrates, preparation methods and uses thereof
06/21/2012US20120157537 NMDA receptor antagonists and their use in inhibiting abnormal hyperphosphorylation of microtubule associated protein tau
06/21/2012US20120157521 Treatment of macular degeneration
06/21/2012US20120157499 Delivery of an active drug to the posterior part of the eye via subconjunctival or periocular delivery of a prodrug
06/21/2012US20120157496 Stabilized and preserved ketotifen ophthalmic compositions
06/21/2012US20120157487 Sulfur derivatives as chemokine receptor modulators
06/21/2012US20120157437 Vla-4 inhibitory drug
06/21/2012US20120157430 N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
06/21/2012US20120157412 Substituted Pyrimidinyl Oxime Kinase Inhibitors
06/21/2012US20120157403 Bicyclic and tricyclic derivatives as thrombin receptor antagonists
06/21/2012US20120157386 Neprilysin inhibitors
06/21/2012US20120157383 Neprilysin inhibitors
06/21/2012US20120157377 Methods to enhance night vision and treatment of night blindness
06/21/2012US20120157371 High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds
06/21/2012US20120156244 Nasal Compositions and Uses Thereof
06/21/2012US20120156233 Vaccine therapy for choroidal neovascularization
06/21/2012US20120156221 Method and Pharmaceutical Composition for Use in the Treatment of Neurodegenerative Disorders
06/21/2012US20120156208 Therapeutic uses of inhibitors of rtp801
06/21/2012US20120156202 Age related macular degeneration treatment
06/21/2012US20120156164 In situ-forming hydrogel for tissue adhesives and biomedical use thereof
06/21/2012US20120156138 Methods and Compositions for the Treatment of Medical Conditions Involving Cellular Reprogramming
06/20/2012EP2465931A1 Light-receiving channel rhodopsin having improved expression efficiency
06/20/2012EP2465509A1 Oligosaccharide composition for treating acute respiratory tract infections
06/20/2012EP2464667A2 N-acylated octasaccharides activating fgfs receptors, their synthesis and their therapeutical application
06/20/2012EP2464387A2 Deuterated water and riboflavin solution for extending singlet oxygen lifetimes in treatment of ocular tissue and method for use
06/20/2012EP2464359A2 N-sulfated oligosaccharides activating fgfs receptors, their synthesis and their therapeutical application
06/20/2012EP2464351A1 Isothiozoles for treating conditions of the eye
06/20/2012EP2464343A1 Ophthalmic drug delivery system containing phospholipid and cholesterol
06/20/2012EP2464232A1 Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
1 ... 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 ... 531